-
公开(公告)号:US20090192153A1
公开(公告)日:2009-07-30
申请号:US12067780
申请日:2006-09-21
申请人: Kazuki Hashimoto , Tomoaki Nakamura , Kei Nakamura , Ayumu Kurimoto , Yoshiaki Isobe , Haruhisa Ogita , Ian Millichip , Thomas Mcinally , Roger Bonnert
发明人: Kazuki Hashimoto , Tomoaki Nakamura , Kei Nakamura , Ayumu Kurimoto , Yoshiaki Isobe , Haruhisa Ogita , Ian Millichip , Thomas Mcinally , Roger Bonnert
IPC分类号: A61K31/5377 , C07D473/34 , A61K31/522 , A61P37/08
CPC分类号: C07D473/18
摘要: An adenine compound or its pharmaceutically acceptable salt as a medicament as shown following formula (1): wherein R1 is optionally substituted alkyl group, etc., X is oxygen atom, etc., A is 4 to 8 membered optionally substituted saturated or unsaturated heterocyclic group containing 1 to 2 hetero atoms selected from 1 to 3 nitrogen atoms, 0 to 1 oxygen atom and 0 to 1 sulfur atom, L1 and L2 are independently straight or branched chain alkylene, or a single bond, R2 is optionally substituted alkyl group, etc.
摘要翻译: 腺嘌呤化合物或其药学上可接受的盐作为如下式(1)所示的药物:其中R 1是任选取代的烷基等,X是氧原子等,A是4至8元任选取代的饱和或不饱和杂环 含有1至2个选自1至3个氮原子,0至1个氧原子和0至1个硫原子的杂原子的基团,L1和L2独立地为直链或支链亚烷基或单键,R2为任选取代的烷基, 等等
-
公开(公告)号:US20110166117A1
公开(公告)日:2011-07-07
申请号:US12982435
申请日:2010-12-30
申请人: Roger Bonnert , Stephen Brough , Andrew Davies , Timothy Luker , Thomas McInally , Ian Millichip , Garry Pairaudeau , Anil Patel , Rukhsana Rasul , Stephen Thom
发明人: Roger Bonnert , Stephen Brough , Andrew Davies , Timothy Luker , Thomas McInally , Ian Millichip , Garry Pairaudeau , Anil Patel , Rukhsana Rasul , Stephen Thom
IPC分类号: A61K31/506 , C07C59/70 , A61K31/192 , A61P11/06 , A61P11/02 , C07D215/06 , A61K31/47 , C07C255/54 , A61K31/277 , C07C205/37 , C07D239/26 , A61K31/505 , C07D213/71 , A61K31/4418 , C07D239/42 , C07D413/04 , A61K31/5377 , A61K31/397
CPC分类号: C07C59/68 , C07C59/70 , C07C65/24 , C07C69/94 , C07C205/35 , C07C205/37 , C07C217/80 , C07C235/42 , C07C255/55 , C07C271/28 , C07C275/32 , C07C311/29 , C07C317/22 , C07C323/18 , C07C2601/02 , C07D205/04 , C07D207/02 , C07D213/61 , C07D213/72 , C07D215/12 , C07D233/52 , C07D239/26 , C07D239/34 , C07D239/42 , C07D277/52 , C07D285/10 , C07D295/192 , C07D295/26 , C07D307/80 , C07D317/54 , C07D333/56 , C07D403/04 , C07D417/04
摘要: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
摘要翻译: 本发明涉及取代的苯氧基乙酸(I)作为治疗呼吸系统疾病的有用的药物化合物,含有它们的药物组合物及其制备方法。
-
公开(公告)号:US20110306610A1
公开(公告)日:2011-12-15
申请号:US13187260
申请日:2011-07-20
申请人: Ayumu KURIMOTO , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
发明人: Ayumu KURIMOTO , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
IPC分类号: A61K31/522 , C07D413/14 , A61P37/08 , A61P37/00 , A61P31/12 , A61P35/00 , C07D473/18 , A61K31/5377
CPC分类号: C07D473/18 , A61K31/522 , A61K31/5377
摘要: The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.
摘要翻译: 本发明提供具有免疫调节活性的8-氧代腺嘌呤化合物,例如干扰素诱导活性,可用作抗病毒剂和抗变应性剂,其由下式(1)表示:[其中环A表示6-10元 芳香族碳环等,R表示卤素原子,烷基等,n表示0-2的整数,Z1表示亚烷基,X2表示氧原子,硫原子,SO2,NR5,CO,CONR5,NR5CO 等等,Y1,Y2和Y3独立地表示单键或亚烷基,X1表示氧原子,硫原子,NR4(R4是氢原子或烷基)或单键,R2表示取代或未取代的烷基 基团,R 1表示氢原子,羟基,烷氧基,烷氧基羰基或卤代烷基]或其药学上可接受的盐。
-
公开(公告)号:US20140045837A1
公开(公告)日:2014-02-13
申请号:US14058064
申请日:2013-10-21
申请人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
发明人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
IPC分类号: C07D473/18
CPC分类号: C07D473/18 , A61K31/522 , A61K31/5377
摘要: The present invention provides an 8-oxoadenine compound having immunomodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.
摘要翻译: 本发明提供具有免疫调节活性的8-氧代腺嘌呤化合物,例如干扰素诱导活性,可用作抗病毒剂和抗变应性剂,其由下式(1)表示:[其中环A表示6-10元 芳香族碳环等,R表示卤素原子,烷基等,n表示0-2的整数,Z1表示亚烷基,X2表示氧原子,硫原子,SO2,NR5,CO,CONR5,NR5CO 等等,Y1,Y2和Y3独立地表示单键或亚烷基,X1表示氧原子,硫原子,NR4(R4是氢原子或烷基)或单键,R2表示取代或未取代的烷基 基团,R 1表示氢原子,羟基,烷氧基,烷氧基羰基或卤代烷基]或其药学上可接受的盐。
-
公开(公告)号:US08575180B2
公开(公告)日:2013-11-05
申请号:US13187260
申请日:2011-07-20
申请人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
发明人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
IPC分类号: A61K31/52 , C07D473/00
CPC分类号: C07D473/18 , A61K31/522 , A61K31/5377
摘要: The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.
摘要翻译: 本发明提供具有免疫调节活性的8-氧代腺嘌呤化合物,例如干扰素诱导活性,可用作抗病毒剂和抗变应性剂,其由下式(1)表示:[其中环A表示6-10元 芳香族碳环等,R表示卤素原子,烷基等,n表示0-2的整数,Z1表示亚烷基,X2表示氧原子,硫原子,SO2,NR5,CO,CONR5,NR5CO 等等,Y1,Y2和Y3独立地表示单键或亚烷基,X1表示氧原子,硫原子,NR4(R4是氢原子或烷基)或单键,R2表示取代或未取代的烷基 基团,R 1表示氢原子,羟基,烷氧基,烷氧基羰基或卤代烷基]或其药学上可接受的盐。
-
公开(公告)号:US20060264435A1
公开(公告)日:2006-11-23
申请号:US10551783
申请日:2004-04-06
申请人: Roger Bonnert , Stephen Brough , Andrew Davies , Timothy Luker , Thomas McInally , Ian Millichip , Garry Pairaudeau , Anil Patel , Rukshana Rasul , Stephen Thom
发明人: Roger Bonnert , Stephen Brough , Andrew Davies , Timothy Luker , Thomas McInally , Ian Millichip , Garry Pairaudeau , Anil Patel , Rukshana Rasul , Stephen Thom
IPC分类号: A61K31/5377 , A61K31/4706 , A61K31/44 , A61K31/513 , A61K31/506
CPC分类号: C07C59/68 , C07C59/70 , C07C65/24 , C07C69/94 , C07C205/35 , C07C205/37 , C07C217/80 , C07C235/42 , C07C255/55 , C07C271/28 , C07C275/32 , C07C311/29 , C07C317/22 , C07C323/18 , C07C2601/02 , C07D205/04 , C07D207/02 , C07D213/61 , C07D213/72 , C07D215/12 , C07D233/52 , C07D239/26 , C07D239/34 , C07D239/42 , C07D277/52 , C07D285/10 , C07D295/192 , C07D295/26 , C07D307/80 , C07D317/54 , C07D333/56 , C07D403/04 , C07D417/04
摘要: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
-
公开(公告)号:US08969362B2
公开(公告)日:2015-03-03
申请号:US14058064
申请日:2013-10-21
申请人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
发明人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
IPC分类号: A61K31/522 , C07D473/18 , A61K31/5377
CPC分类号: C07D473/18 , A61K31/522 , A61K31/5377
摘要: The present invention provides an 8-oxoadenine compound having immunomodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.
摘要翻译: 本发明提供具有免疫调节活性的8-氧代腺嘌呤化合物,例如干扰素诱导活性,可用作抗病毒剂和抗变应性剂,其由下式(1)表示:[其中环A表示6-10元 芳香族碳环等,R表示卤素原子,烷基等,n表示0-2的整数,Z1表示亚烷基,X2表示氧原子,硫原子,SO2,NR5,CO,CONR5,NR5CO 等等,Y1,Y2和Y3独立地表示单键或亚烷基,X1表示氧原子,硫原子,NR4(R4是氢原子或烷基)或单键,R2表示取代或未取代的烷基 基团,R 1表示氢原子,羟基,烷氧基,烷氧基羰基或卤代烷基]或其药学上可接受的盐。
-
公开(公告)号:US08158820B2
公开(公告)日:2012-04-17
申请号:US10551783
申请日:2004-04-06
申请人: Roger Bonnert , Stephen Brough , Andrew Davies , Timothy Luker , Thomas McInally , Ian Millichip , Garry Pairaudeau , Anil Patel , Rukhsana Rasul , Stephen Thom
发明人: Roger Bonnert , Stephen Brough , Andrew Davies , Timothy Luker , Thomas McInally , Ian Millichip , Garry Pairaudeau , Anil Patel , Rukhsana Rasul , Stephen Thom
CPC分类号: C07C59/68 , C07C59/70 , C07C65/24 , C07C69/94 , C07C205/35 , C07C205/37 , C07C217/80 , C07C235/42 , C07C255/55 , C07C271/28 , C07C275/32 , C07C311/29 , C07C317/22 , C07C323/18 , C07C2601/02 , C07D205/04 , C07D207/02 , C07D213/61 , C07D213/72 , C07D215/12 , C07D233/52 , C07D239/26 , C07D239/34 , C07D239/42 , C07D277/52 , C07D285/10 , C07D295/192 , C07D295/26 , C07D307/80 , C07D317/54 , C07D333/56 , C07D403/04 , C07D417/04
摘要: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
摘要翻译: 本发明涉及取代的苯氧基乙酸(I)作为治疗呼吸系统疾病的有用的药物化合物,含有它们的药物组合物及其制备方法。
-
公开(公告)号:US20090099216A1
公开(公告)日:2009-04-16
申请号:US12067781
申请日:2006-09-22
申请人: Ian Millichip , Thomas McInally , Roger Bonnert
发明人: Ian Millichip , Thomas McInally , Roger Bonnert
IPC分类号: A61K31/522 , C07D473/18
CPC分类号: C07D473/18
摘要: A novel adenine compound represented by the formula (1): wherein Z represents (un)substituted alkylene, a single bond, etc.; R1 represents an (un)substituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, or heteroaryl group; R2 represents hydrogen or (un)substituted alkyl; R3, R4 and R5 each independently represents an (un)substituted alkyl, alkenyl, alkynyl, aryl, or heteroaryl group, provided that R3 and R5 may be bonded to each other to form a 3- to 7-membered, saturated carbocycle or heterocycle in cooperation with the adjacent carbon atom; and X represents oxygen, sulfur, SO2, NR6 (R6 represents hydrogen or alkyl), or a single bond, or a pharmaceutically acceptable salt of the compound. The compound and salt are useful as a medicine.
摘要翻译: 由式(1)表示的新型腺嘌呤化合物:其中Z表示(un)取代的亚烷基,单键等; R1表示(un)取代的烷基,烯基,炔基,环烷基,芳基或杂芳基; R2代表氢或(未)取代的烷基; R 3,R 4和R 5各自独立地表示(未)取代的烷基,烯基,炔基,芳基或杂芳基,条件是R 3和R 5可以彼此键合以形成3-至7-元饱和碳环或杂环 与邻近的碳原子合作; X表示氧,硫,SO 2,NR 6(R 6表示氢或烷基)或单键或该化合物的药学上可接受的盐。 化合物和盐可用作药物。
-
公开(公告)号:US20070190071A1
公开(公告)日:2007-08-16
申请号:US10593691
申请日:2005-03-24
申请人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
发明人: Ayumu Kurimoto , Kazuki Hashimoto , Yoshiaki Isobe , Stephen Brough , Ian Millichip , Hiroki Wada , Roger Bonnert , Thomas Mcinally
IPC分类号: A61K31/52 , A61K31/522 , C07D473/10
CPC分类号: C07D473/18 , A61K31/522 , A61K31/5377
摘要: The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group]or its pharmaceutically acceptable salt.
摘要翻译: 本发明提供具有免疫调节活性的8-氧代腺嘌呤化合物,例如干扰素诱导活性,可用作抗病毒剂和抗变应性剂,其由下式(1)表示:[其中环A表示6-10元 芳香族碳环等,R表示卤素原子,烷基等,n表示0〜2的整数,Z 1表示亚烷基,X 2, 表示氧原子,硫原子,SO 2,NR 5,CO,CONR 5,NR 5 CO和 Y 1,Y 2和Y 3独立地表示单键或亚烷基,X 1,O 2, >表示氧原子,硫原子,NR 4(R 4)是氢原子或烷基或单键,R 2表示 取代或未取代的烷基,R 1表示氢原子,羟基,烷氧基,烷氧基羰基或 芳烷基]或其药学上可接受的盐。
-
-
-
-
-
-
-
-
-